A glimpse to the highlights of our ribbon-cutting opening event of our new colocalized Selexis and KBI CDMO facility in Geneva
We recently held a ribbon-cutting at our state-of-the-art facility in Geneva, Switzerland. Designed to directly serve the increased demand for biopharmaceutical drug development and manufacturing in Europe, the facility will support an integrated, end-to-end process of Selexis’ cell line development (CLD) services along with KBI’s contract development and manufacturing services for industry clients throughout the immediate region and beyond.Together, Selexis and KBI Biopharma are globally known for tackling some of the most challenging biologics projects.